CA
ALNY icon

Commerzbank Aktiengesellschaft’s Alnylam Pharmaceuticals ALNY Stock Holding History

Commerzbank Aktiengesellschaft’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-6,110
Closed -$443K – 841
2019
Q2 		$443K Buy
6,110
+3,816
+166% +$293K ﹤0.01% 768
2019
Q1 		$214K Sell
2,294
-2,902
-56% -$243K ﹤0.01% 785
2018
Q4 		$379K Buy
5,196
+2,511
+94% +$193K ﹤0.01% 721
2018
Q3 		$235K Buy
2,685
+249
+10% +$25K ﹤0.01% 845
2018
Q2 		$240K Buy
+2,436
New +$242K ﹤0.01% 812
2016
Q4 		– Sell
-3,262
Closed -$221K – 974
2016
Q3 		$221K Sell
3,262
-1,095
-25% -$77.3K ﹤0.01% 816
2016
Q2 		$242K Sell
4,357
-605
-12% -$38.1K ﹤0.01% 886
2016
Q1 		$311K Sell
4,962
-466
-9% -$31K ﹤0.01% 857
2015
Q4 		$511K Buy
5,428
+163
+3% +$15.1K ﹤0.01% 862
2015
Q3 		$423K Sell
5,265
-497
-9% -$55.2K ﹤0.01% 839
2015
Q2 		$691K Buy
5,762
+3,449
+149% +$412K ﹤0.01% 909
2015
Q1 		$242K Sell
2,313
-1,073
-32% -$109K ﹤0.01% 1059
2014
Q4 		$328K Buy
+3,386
New +$314K ﹤0.01% 1066

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

Commerzbank Aktiengesellschaft's ALNY Position: Q3 2019 in Review

Commerzbank Aktiengesellschaft sold out of Alnylam Pharmaceuticals (ALNY) in Q3 2019, closing a stake of 6,110 shares — an estimated $443K sold.

Commerzbank Aktiengesellschaft first reported a position in ALNY in Q4 2014 and held it in 13 quarters. The position peaked at $691K in Q2 2015. 281 funds tracked by Wall St. Rank hold ALNY as of Q3 2019.

  • Commerzbank Aktiengesellschaft reported no remaining Alnylam Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
  • Commerzbank Aktiengesellschaft sold 6,110 Alnylam Pharmaceuticals shares in Q3 2019, an estimated $443K.
  • Commerzbank Aktiengesellschaft first reported a position in Alnylam Pharmaceuticals in Q4 2014 and held it in 13 quarters.
  • Commerzbank Aktiengesellschaft's Alnylam Pharmaceuticals position peaked at $691K in Q2 2015.
  • 281 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q3 2019.

Based on Commerzbank Aktiengesellschaft's 13F filing for Q3 2019, filed 17 Oct 2019.